GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ulisse Biomed SpA (MIL:UBM) » Definitions » FCF Yield %

Ulisse Biomed SpA (MIL:UBM) FCF Yield % : -19.07 (As of Apr. 17, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Ulisse Biomed SpA FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Ulisse Biomed SpA's Trailing 12-Month Free Cash Flow is €-3.59 Mil, and Market Cap is €18.85 Mil. Therefore, Ulisse Biomed SpA's FCF Yield % for today is -19.07%.

The historical rank and industry rank for Ulisse Biomed SpA's FCF Yield % or its related term are showing as below:

MIL:UBM' s FCF Yield % Range Over the Past 10 Years
Min: -20.33   Med: -7.72   Max: -1.67
Current: -19.07


During the past 7 years, the highest FCF Yield % of Ulisse Biomed SpA was -1.67%. The lowest was -20.33%. And the median was -7.72%.

MIL:UBM's FCF Yield % is ranked worse than
54.61% of 1498 companies
in the Biotechnology industry
Industry Median: -15.34 vs MIL:UBM: -19.07

Ulisse Biomed SpA's FCF Margin % for the quarter that ended in Dec. 2024 was -296.91%.


Ulisse Biomed SpA FCF Yield % Historical Data

The historical data trend for Ulisse Biomed SpA's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ulisse Biomed SpA FCF Yield % Chart

Ulisse Biomed SpA Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
FCF Yield %
Get a 7-Day Free Trial - -5.04 -14.59 -4.16 -19.96

Ulisse Biomed SpA Semi-Annual Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -15.71 -9.91 -3.33 -17.27 -18.17

Competitive Comparison of Ulisse Biomed SpA's FCF Yield %

For the Biotechnology subindustry, Ulisse Biomed SpA's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ulisse Biomed SpA's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ulisse Biomed SpA's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Ulisse Biomed SpA's FCF Yield % falls into.


;
;

Ulisse Biomed SpA FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Ulisse Biomed SpA's FCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.594 / 18.008676
=-19.96%

Ulisse Biomed SpA's annualized FCF Yield % for the quarter that ended in Dec. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-1.636 * 2 / 18.008676
=-18.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ulisse Biomed SpA FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Ulisse Biomed SpA FCF Yield % Related Terms

Thank you for viewing the detailed overview of Ulisse Biomed SpA's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Ulisse Biomed SpA Business Description

Traded in Other Exchanges
N/A
Address
Area Science Park - SS14 km.163, 5, Basovizza, ITA, 34149
Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.

Ulisse Biomed SpA Headlines

No Headlines